Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hartmut Goldschmidt

Showing results (111-120 of 539) with videos related to

Pageof 54
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 26, 2016
Storage Duration of Autologous Stem Cell Preparations Has No Impact on Hematopoietic Recovery after TransplantationKatharina Lisenko, Petra Pavel, Mark Kriegsmann, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|March 30, 2018
Platelet Count before Peripheral Blood Stem Cell Mobilization Is Associated with the Need for Plerixafor But Not with the Collection ResultMarc-Andrea Baertsch, Katharina Kriegsmann, Petra Pavel, et al.
American Journal of Hematology|August 11, 2016
Baseline characteristics, chromosomal alterations, and treatment affecting prognosis of deletion 17p in newly diagnosed myelomaMaximilian Merz, Thomas Hielscher, Anja Seckinger, et al.
Cancer Medicine|December 29, 2017
Analysis of long-term survival in multiple myeloma after first-line autologous stem cell transplantation: impact of clinical risk factors and sustained responseNicola Lehners, Natalia Becker, Axel Benner, et al.
Blood|November 25, 2004
Enrichment of functional CD8 memory T cells specific for MUC1 in bone marrow of patients with multiple myelomaCarmen Choi, Mathias Witzens, Marianna Bucur, et al.
Hematological Oncology|March 21, 2017
Bortezomib-induced peripheral neuropathy: A genome-wide association study on multiple myeloma patientsChiara Campo, Miguel Inacio da Silva Filho, Niels Weinhold, et al.
Cancer Medicine|April 26, 2016
Flow cytometry-based characterization of underlying clonal B and plasma cells in patients with light chain amyloidosisKatharina Lisenko, Stefan O Schönland, Anna Jauch, et al.
British Journal of Haematology|February 3, 2009
Gene expression of anti- and pro-apoptotic proteins in malignant and normal plasma cellsMichel Jourdan, Thierry Reme, Hartmut Goldschmidt, et al.
European Journal of Haematology|June 20, 2024
Retrospective study on pomalidomide-PACE as a salvage regimen in aggressive relapsed and refractory multiple myelomaDeniz Gezer, Melanie Schmitt Nogueira, Martin Kirschner, et al.
Annals of Hematology|August 1, 2008
Effective prophylaxis of thromboembolic complications with low molecular weight heparin in relapsed multiple myeloma patients treated with lenalidomide and dexamethasoneUlrike Klein, Florentina Kosely, Jens Hillengass, et al.
Pageof 54

Showing results (111-120 of 539) with videos related to

Sort By:
Pageof 54
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 26, 2016
Storage Duration of Autologous Stem Cell Preparations Has No Impact on Hematopoietic Recovery after TransplantationKatharina Lisenko, Petra Pavel, Mark Kriegsmann, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|March 30, 2018
Platelet Count before Peripheral Blood Stem Cell Mobilization Is Associated with the Need for Plerixafor But Not with the Collection ResultMarc-Andrea Baertsch, Katharina Kriegsmann, Petra Pavel, et al.
American Journal of Hematology|August 11, 2016
Baseline characteristics, chromosomal alterations, and treatment affecting prognosis of deletion 17p in newly diagnosed myelomaMaximilian Merz, Thomas Hielscher, Anja Seckinger, et al.
Cancer Medicine|December 29, 2017
Analysis of long-term survival in multiple myeloma after first-line autologous stem cell transplantation: impact of clinical risk factors and sustained responseNicola Lehners, Natalia Becker, Axel Benner, et al.
Blood|November 25, 2004
Enrichment of functional CD8 memory T cells specific for MUC1 in bone marrow of patients with multiple myelomaCarmen Choi, Mathias Witzens, Marianna Bucur, et al.
Hematological Oncology|March 21, 2017
Bortezomib-induced peripheral neuropathy: A genome-wide association study on multiple myeloma patientsChiara Campo, Miguel Inacio da Silva Filho, Niels Weinhold, et al.
Cancer Medicine|April 26, 2016
Flow cytometry-based characterization of underlying clonal B and plasma cells in patients with light chain amyloidosisKatharina Lisenko, Stefan O Schönland, Anna Jauch, et al.
British Journal of Haematology|February 3, 2009
Gene expression of anti- and pro-apoptotic proteins in malignant and normal plasma cellsMichel Jourdan, Thierry Reme, Hartmut Goldschmidt, et al.
European Journal of Haematology|June 20, 2024
Retrospective study on pomalidomide-PACE as a salvage regimen in aggressive relapsed and refractory multiple myelomaDeniz Gezer, Melanie Schmitt Nogueira, Martin Kirschner, et al.
Annals of Hematology|August 1, 2008
Effective prophylaxis of thromboembolic complications with low molecular weight heparin in relapsed multiple myeloma patients treated with lenalidomide and dexamethasoneUlrike Klein, Florentina Kosely, Jens Hillengass, et al.
Pageof 54